Population seroprevalence of SARS-CoV-2 antibodies in Anambra State, South-East, Nigeria
GHDx Entry last modified on: May 12, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1451 - 1500 of 1636
Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
GHDx Entry last modified on: Apr 10, 2023
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia
GHDx Entry last modified on: Mar 14, 2022
I SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee
GHDx Entry last modified on: Jan 31, 2024
Logistics Workers Are a Key Factor for SARS-CoV-2 Spread in Brazilian Small Towns: Case-Control Study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Post COVID-19 sequelae: A prospective observational study from Northern India
GHDx Entry last modified on: Jan 31, 2024
Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York
GHDx Entry last modified on: Jan 31, 2024
Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13062 positive pregnancies including 176 maternal deaths in Mexico
GHDx Entry last modified on: Apr 10, 2023
Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis
GHDx Entry last modified on: Apr 10, 2023
Prevalence and Neighborhood Geomapping of COVID-19 in an Underserved Chicago Pregnant Population
GHDx Entry last modified on: Apr 10, 2023
Development Assistance for COVID-19 Vaccine Delivery 2020-2021
GHDx Entry last modified on: Mar 16, 2023
Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients
GHDx Entry last modified on: Mar 22, 2024
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
GHDx Entry last modified on: Mar 22, 2024
Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea
GHDx Entry last modified on: Mar 22, 2024
Long COVID" results after hospitalization for SARS-CoV-2 infection
GHDx Entry last modified on: Mar 22, 2024
Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset
GHDx Entry last modified on: Mar 22, 2024
Türkiye Deaths By Cause, Sex, and Age Group 2020
GHDx Entry last modified on: Mar 12, 2025
Is there a difference between GBS triggered by COVID-19 and those of other origins?
GHDx Entry last modified on: Oct 23, 2024
Sri Lanka Epidemiology Unit Coronavirus Disease 2019 (COVID-19) Situation Report 2020-2022
Coronavirus disease 2019 (COVID-19) - Situation Report
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
GHDx Entry last modified on: Mar 14, 2022
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states. Preprint
Scientific literature:
Household
Seroprevalence of COVID-19 in Niger State. Preprint
GHDx Entry last modified on: Mar 4, 2024
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
GHDx Entry last modified on: Mar 14, 2022
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series
GHDx Entry last modified on: Mar 14, 2022
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
GHDx Entry last modified on: Mar 14, 2022
Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York
GHDx Entry last modified on: Jan 31, 2024
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020
Report:
Epi surveillance
United States - Colorado Department of Public Health and Environment COVID19 State-Level Expanded Case Data 2019-2022
CDPHE COVID19 State-Level Expanded Case Data
SARS-CoV-2 Daily and Cumulative Infection Estimates 2019-2021
GHDx Entry last modified on: Jun 15, 2022
Social Determinants of Health and Risk of SARS-CoV-2 Infection in Community-Dwelling Older Adults Living in a Rural Latin American Setting
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in April/May 2020 and August 2019
GHDx Entry last modified on: Jan 9, 2025
Sustained seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
Coronavirus and depression in adults, Great Britain: June 2020
Survey:
Individual - Interview - Longitudinal
Chhattisgarh's excess deaths at least 4.8 times COVID-19 toll
GHDx Entry last modified on: Nov 12, 2021
Missing Diagnoses during the COVID-19 Pandemic: A Year in Review
GHDx Entry last modified on: Apr 10, 2023
The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal
GHDx Entry last modified on: Apr 10, 2023
The "COVID-19 Pandemic Gap" and Its Influence on Oncologic Outcomes of Bladder Cancer
GHDx Entry last modified on: Apr 10, 2023
Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: asingle-centre cohort study
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019-April 2020
GHDx Entry last modified on: Jan 31, 2024
Pattern of breast cancer presentation during the COVID-19 pandemic: results from a cohort study in the UK
GHDx Entry last modified on: Apr 10, 2023
Impact of COVID 19 on red flag discussions for haematological malignancies within the Belfast trust
GHDx Entry last modified on: Apr 10, 2023
Retrospective study of COVID-19 seroprevalence among tissue donors at the onset of the outbreak before implementation of strict lockdown measures in France
GHDx Entry last modified on: Mar 14, 2022
The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 elimination
GHDx Entry last modified on: Apr 10, 2023
Subscribe